RE: Royal Marsden Sky News22 Nov 2022 08:49
P1a passed.
P1b should follow in quick order.
Onto P2 and gather data.
Prove entire platform and 50% of TMAC.
Multiple therapeutics
2 platforms.
Hundreds of billions in potential revenue.
Get 6k to market and licence 3996 will keep us independent.
The issue the green boxes have is they largely don’t want it to succeed as it’ll no longer be their little trading baby because, to them, money is more important than lives being saved. They’re unsympathetic sociopaths. I believe the success of AVA6k is a penicillin moment. Many simply cannot believe that, they can’t get their head around the idea that this little biotech may have the answer to millions of people suffering. But so far, the signs suggest they do.
The question they ask is “then why are we at a lowly £300m?” Because people have never heard of us and because people have us in the same category as ADV, HE1 and SNG….. stocks for dreamers. If we crack FAP, the potential for humanity and the potential for investors is staggering. And that is a fact! Indisputable, cast in stone, fact. Make cancer treatment bearable and you become a global behemoth in Oncology.